Android app Apple app link

Long Leaf Partners Fund's Comment on Regeneron (REGN)

By Yahoo! Finance   |   1 month ago
Long Leaf Partners Fund's Comment on Regeneron (REGN)

Longleaf Partners Fund's third-quarter 2025 investor letter discusses its flat performance, focusing on investments in real assets and brands. Highlighted stock Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) saw positive growth and share repurchases.

Read More

Did you find this insightful?

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.